DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager

DSM-Firmenich AG

AEX:DSFIR

Watchlist

Dividends

Discount Rate

Price: 107.25 EUR 2.29% Market Closed

Market Cap: 28.5B EUR

Have any thoughts about
DSM-Firmenich AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 107.25 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DSFIR Alert

DSM-Firmenich AG

107.25

+2.40 (+2.29%)

52 Week Range	85.51 123.65
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

DSM-Firmenich AG

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DSM-Firmenich AG.

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DSM-Firmenich AG.

Provide P/S
for DSM-Firmenich AG.

Provide P/E
for DSM-Firmenich AG.

Provide P/OCF
for DSM-Firmenich AG.

Provide P/FCFE
for DSM-Firmenich AG.

Provide P/B
for DSM-Firmenich AG.

Provide EV/S
for DSM-Firmenich AG.

Provide EV/GP
for DSM-Firmenich AG.

Provide EV/EBITDA
for DSM-Firmenich AG.

Provide EV/EBIT
for DSM-Firmenich AG.

Provide EV/OCF
for DSM-Firmenich AG.

Provide EV/FCFF
for DSM-Firmenich AG.

Provide EV/IC
for DSM-Firmenich AG.

Show me price targets
for DSM-Firmenich AG made by professional analysts.

What are the Revenue projections
for DSM-Firmenich AG?

How accurate were the past Revenue estimates
for DSM-Firmenich AG?

What are the Net Income projections
for DSM-Firmenich AG?

How accurate were the past Net Income estimates
for DSM-Firmenich AG?

What are the EPS projections
for DSM-Firmenich AG?

How accurate were the past EPS estimates
for DSM-Firmenich AG?

What are the EBIT projections
for DSM-Firmenich AG?

How accurate were the past EBIT estimates
for DSM-Firmenich AG?

Compare the revenue forecasts
for DSM-Firmenich AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DSM-Firmenich AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DSM-Firmenich AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of DSM-Firmenich AG compared to its peers.

Compare the P/E ratios
of DSM-Firmenich AG against its peers.

Discuss the investment returns and shareholder value creation
comparing DSM-Firmenich AG with its peers.

Analyze the financial leverage
of DSM-Firmenich AG compared to its main competitors.

Show all profitability ratios
for DSM-Firmenich AG.

Provide ROE
for DSM-Firmenich AG.

Provide ROA
for DSM-Firmenich AG.

Provide ROIC
for DSM-Firmenich AG.

Provide ROCE
for DSM-Firmenich AG.

Provide Gross Margin
for DSM-Firmenich AG.

Provide Operating Margin
for DSM-Firmenich AG.

Provide Net Margin
for DSM-Firmenich AG.

Provide FCF Margin
for DSM-Firmenich AG.

Show all solvency ratios
for DSM-Firmenich AG.

Provide D/E Ratio
for DSM-Firmenich AG.

Provide D/A Ratio
for DSM-Firmenich AG.

Provide Interest Coverage Ratio
for DSM-Firmenich AG.

Provide Altman Z-Score Ratio
for DSM-Firmenich AG.

Provide Quick Ratio
for DSM-Firmenich AG.

Provide Current Ratio
for DSM-Firmenich AG.

Provide Cash Ratio
for DSM-Firmenich AG.

What is the historical Revenue growth
over the last 5 years for DSM-Firmenich AG?

What is the historical Net Income growth
over the last 5 years for DSM-Firmenich AG?

What is the current Free Cash Flow
of DSM-Firmenich AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for DSM-Firmenich AG.

P/E
Price to Earnings

13.4

Current

12.2

Median

21.8

Industry

Higher than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

13.4

Market Cap

28.5B EUR

Net Income

2.1B EUR

All Countries

Forward Multiples

			Market Cap	P/E
CH	D	DSM-Firmenich AG AEX:DSFIR	28.5B EUR	13.4
US		Sherwin-Williams Co NYSE:SHW	97.8B USD	38.2
JP		Shin-Etsu Chemical Co Ltd TSE:4063	11.2T JPY	21.8
US		Ecolab Inc NYSE:ECL	69.8B USD	34.1
CH		Givaudan SA SIX:GIVN	36.3B CHF	35.2
US		Dupont De Nemours Inc NYSE:DD	34.8B USD	43.6
CN		Wanhua Chemical Group Co Ltd SSE:600309	232B CNY	15.3
US		PPG Industries Inc NYSE:PPG	28.5B USD	19.1
IN		Asian Paints Ltd NSE:ASIANPAINT	2.4T INR	46.7
DK		Novozymes A/S CSE:NZYM B	165.6B DKK	54.8
US		International Flavors & Fragrances Inc NYSE:IFF	23.2B USD	-10

				Earnings Growth
CH	D	DSM-Firmenich AG AEX:DSFIR	Average P/E: 32.2 13.4	-42%
US		Sherwin-Williams Co NYSE:SHW	38.2	52%
JP		Shin-Etsu Chemical Co Ltd TSE:4063	21.8	40%
US		Ecolab Inc NYSE:ECL	34.1	76%
CH		Givaudan SA SIX:GIVN	35.2	46%
US		Dupont De Nemours Inc NYSE:DD	43.6	400%
CN		Wanhua Chemical Group Co Ltd SSE:600309	15.3	41%
US		PPG Industries Inc NYSE:PPG	19.1	80%
IN		Asian Paints Ltd NSE:ASIANPAINT	46.7	15%
DK		Novozymes A/S CSE:NZYM B	54.8	N/A
US		International Flavors & Fragrances Inc NYSE:IFF	Negative Multiple: -10	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

35.2

2-Years Forward

P/E

26.7

3-Years Forward

P/E

23.3

DSM-Firmenich AG
AEX:DSFIR

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG AEX:DSFIR

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG
AEX:DSFIR

P/E
Price to Earnings